Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Edwards Lifesciences (EW) Tops Q3 EPS by 2c
October 24, 2017 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.88, $0.02 better than the analyst estimate of $0.86. Revenue for the quarter came in at $821.5 million versus the consensus estimate of $831.98 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2017 EPS of $0.84-$0.94, versus the consensus of $0.91.... More
